April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Adenoviral vector-mediated transfer of erythropoietin and GFP to the lacrimal gland in rat
Author Affiliations & Notes
  • Ana Carolina Dias
    Ophtalmology, FMRP-USP, Ribeirão Preto, Brazil
  • Lara C Dias
    Ophtalmology, FMRP-USP, Ribeirão Preto, Brazil
  • Luis Fernando Nominato
    Ophtalmology, FMRP-USP, Ribeirão Preto, Brazil
  • Eduardo M Rocha
    Ophtalmology, FMRP-USP, Ribeirão Preto, Brazil
  • Footnotes
    Commercial Relationships Ana Dias, None; Lara Dias, None; Luis Fernando Nominato, None; Eduardo Rocha, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 51. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ana Carolina Dias, Lara C Dias, Luis Fernando Nominato, Eduardo M Rocha; Adenoviral vector-mediated transfer of erythropoietin and GFP to the lacrimal gland in rat. Invest. Ophthalmol. Vis. Sci. 2014;55(13):51.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Our group has been studying the feasibility of viral vector gene transfer to the lacrimal gland. The aims of this work are: a) to evaluated changes in the tear secretion and cells of ocular surface, b) to evaluate the changes in the lacrimal gland of rats with an adenovirus encoding the human erythropoietin (Epo) gene (AdLTR2EF1a-hEPO) or GFP (AdGFP).

Methods: Male Wistar rats 6-8 weeks were divided into 3 groups (n = 5/group), where the control group received an injection of saline and the treated group received an injection of erythropoietin adenovirus (Ad-Epo) (20ul, 1012/ml ) and a group that received an injection of GFP adenovirus (Ad-GFP) (20 ul, 1012/ml) in the lacrimal gland. Data was collected 6 days after injection. The main parameters evaluated were tear secretion (phenol red thread), lacrimal gland (LG) and ocular globe histology, ocular surface impression citology (IC), expression of erythropoietin in the western blotting.

Results: Tear secretion was not affected by viral vector gene transfer (control 5 ± 3.46mm, AdEpo 4± 1.73 mm and AdGFP 7± 1.29mm (p>0.05). IC revealed significant changes in cornea epithelia in AdEpo and AdGFP compared to controls (p=0.0079). At the6th day, there was no change in lacrimal gland or cornea histology compared to controls. The cornea epithelial thickness was 20.98± 3.16 µm in the control, 24.91± 1.08 µm in the AdEpo group and 24.72± 4.84 µm in the AdGFP group. Erythropoietin expression was significantly higher in transfected LG than controls (p<0.05).

Conclusions: Adenovirus vector gene transfer was safe for lacrimal gland structure and function. Their impact on cornea epithelia needs further clarification. The present work offers additional information on the feasibility of gene therapy in the lacrimal gland. Support: FAPESP, CNPq, NAP-FTO USP, Capes.

Keywords: 576 lacrimal gland • 411 adenovirus • 561 injection  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.